Neurocrine Biosciences

📍 San Diego, United States🗓 Founded 1992👥 1,261 employees💰 Last funded 1989
Biotechnology Research🌐 neurocrine.com
Website LinkedIn
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis* and uterine fibroids* , as well as clinical programs in multiple therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. Review our Community Guidelines: https://bit.ly/3L8M8hx *in collaboration with AbbVie
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
1992
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Neurocrine Biosciences?
Neurocrine Biosciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Neurocrine Biosciences last raise funding?
The most recent investment in Neurocrine Biosciences recorded on gritt.io was in 1989.
When was Neurocrine Biosciences founded?
Neurocrine Biosciences was founded in 1992.
What industry is Neurocrine Biosciences in?
Neurocrine Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neurocrine Biosciences based?
Neurocrine Biosciences is headquartered in San Diego, United States.